|
WO2021022058A2
|
|
Antiarrhythmic formulation
|
|
US2021030732A1
|
|
Antiarrhythmic formulation
|
|
WO2019236694A1
|
|
Methods for diagnosing brugada syndrome using an aerosol
|
|
WO2019183470A2
|
|
A novel method to slow ventricular rate
|
|
AU2018266199A1
|
|
Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
|
|
KR20180102201A
|
|
Combination of electronic monitoring and inhalation pharmacotherapy to manage cardiac arrhythmias, including atrial fibrillation
|
|
AU2016256776A1
|
|
Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
|
|
US2018008540A1
|
|
Unit aerosol doses for anticoagulation
|
|
AU2013248242A1
|
|
Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
|
|
AU2010226613A1
|
|
Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
|
